Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-02-27

Clinical Trial Update: Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease [NA]

View source ↗

Summary

A clinical trial evaluating the effect of niacin on HDL cholesterol in people with peripheral arterial disease has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Niacin (nicotinic acid)

Snippet

Sponsor: Bayside Health | Conditions: Peripheral Arterial Disease | NA | Status: TERMINATED